Michael Trang

Statistics

Publications

Citations

183

H-Index

Active since

2016

Affiliations

Institute for Clinical Pharmacodynamics (United States)(Current)

Paratek Pharmaceuticals (United States)

JMI Laboratories

Michael Trang is an author at Institute for Clinical Pharmacodynamics (United States) specializing in pharmacology, pharmacokinetics of antimicrobials, and pharmacokinetics.

ORCID

Publications per year

2016–2024

Publications

MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni et al. · Molecular Cancer Therapeutics · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

Elizabeth A. Lakota, Scott A. Van Wart, Michael Trang et al. · Antimicrobial Agents and Chemotherapy · 2020 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

Michael Trang, Julie D. Seroogy, Scott A. Van Wart et al. · Antimicrobial Agents and Chemotherapy · 2019 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Sujata M. Bhavnani, Jeffrey Hammel, Elizabeth A. Lakota et al. · Antimicrobial Agents and Chemotherapy · 2023 · 19 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients

Michael Trang, David C. Griffith, Sujata M. Bhavnani et al. · Antimicrobial Agents and Chemotherapy · 2021 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 10